Medicare Enrolled
Dr. Priya Nair, M.D.
Rheumatology · Dallas, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Nair from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Nair?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Nair
Dr. Priya Nair is a rheumatology specialist in Dallas, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Nair performed 12,228 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Nair received a total of $52,943 from 41 pharmaceutical and/or device companies across 1005 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Nair is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 37% volume in TX
$52,943 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗12,228
Medicare services
Top 37% in TX for rheumatology
Not available
Unique patients (not deduplicated)
$26
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
4,340 | $26 | $35 |
| Denosumab injection (Prolia/Xgeva) | 3,660 | $18 | $23 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
782 | $88 | $130 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
506 | $10 | $12 |
| Erythrocyte sedimentation rate (ESR) test A blood test that measures how quickly red blood cells settle in a test tube to detect inflammation in the body. This specific method is performed manually rather than using an automated machine. |
491 | $4 | $5 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
467 | $8 | $8 |
| C-reactive protein test (inflammation marker) A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body. |
426 | $5 | $6 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
315 | $3 | $3 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
234 | $55 | $76 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
185 | $29 | $30 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
104 | $49 | $66 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
103 | $97 | $142 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
99 | $21 | $29 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
94 | $61 | $92 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
59 | $2 | $4 |
| Complement and antigen measurement A laboratory test to measure levels of complement proteins and antigens in the blood. |
38 | $11 | $14 |
| Complement function test A blood test that measures the activity of complement proteins, which are part of the immune system. |
38 | $11 | $15 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
38 | $43 | $57 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
36 | $107 | $170 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
33 | $48 | $71 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
30 | $12 | $22 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
25 | $3 | $4 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
23 | $36 | $55 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
19 | $4 | $5 |
| Injection, methylprednisolone acetate, 40 mg | 16 | $5 | $7 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
16 | $8 | $14 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
15 | $14 | $23 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
13 | $6 | $9 |
| New patient office visit, complex (60-74 min) | 12 | $153 | $222 |
| Trabecular bone score calculation This procedure calculates the trabecular bone score using imaging data to assess bone microarchitecture. It includes interpretation and a report on fracture risk. |
11 | $32 | $41 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
37.2% high complexity
33.6% medium
29.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$52,943
Total received (2018-2024)
Avg $7,563/year across 7 years
Top 10% in TX for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
1,005
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,929
2023
$2,655
2022
$2,434
2021
$2,739
2020
$9,992
2019
$29,055
2018
$4,140
Payments by company (2024)
ABBVIE INC.
$596
Amgen Inc.
$276
GlaxoSmithKline, LLC.
$233
Novartis Pharmaceuticals Corporation
$230
ANI Pharmaceuticals, Inc.
$190
Lilly USA, LLC
$120
Boehringer Ingelheim Pharmaceuticals, Inc.
$60
E.R. Squibb & Sons, L.L.C.
$47
Fresenius Kabi USA, LLC
$40
SCILEX PHARMACEUTICALS INC.
$23
UCB, Inc.
$21
AstraZeneca Pharmaceuticals LP
$17
DePuy Synthes Sales Inc.
$17
Janssen Biotech, Inc.
$16
Radius Health, Inc.
$16
Mallinckrodt Hospital Products Inc.
$15
Kiniksa Pharmaceuticals International, plc
$13
Top 3 companies account for 57.2% of 2024 payments
All-time payments by company (2018-2024) ›
AbbVie, Inc.
$29,158
AbbVie Inc.
$9,933
ABBVIE INC.
$2,602
Amgen Inc.
$2,185
Novartis Pharmaceuticals Corporation
$1,797
Janssen Biotech, Inc.
$1,403
PFIZER INC.
$839
GlaxoSmithKline, LLC.
$770
Lilly USA, LLC
$673
Horizon Therapeutics plc
$470
GENZYME CORPORATION
$369
AstraZeneca Pharmaceuticals LP
$341
UCB, Inc.
$307
Genentech USA, Inc.
$277
Celgene Corporation
$219
E.R. Squibb & Sons, L.L.C.
$200
ANI Pharmaceuticals, Inc.
$190
Radius Health, Inc.
$159
Boehringer Ingelheim Pharmaceuticals, Inc.
$143
Mallinckrodt LLC
$142
Mallinckrodt Hospital Products Inc.
$70
Aurinia Pharma U.S., Inc.
$70
Antares Pharma, Inc.
$69
MEDEXUS PHARMA, INC.
$62
DePuy Synthes Sales Inc.
$53
Organon LLC
$51
Mallinckrodt Enterprises LLC
$51
West-Ward Pharmaceuticals
$42
TerSera Therapeutics LLC
$40
SANOFI-AVENTIS U.S. LLC
$40
Fresenius Kabi USA, LLC
$40
Exeltis, USA Inc.
$28
MEDAC PHARMA, INC.
$23
SCILEX PHARMACEUTICALS INC.
$23
Regeneron Healthcare Solutions, Inc.
$21
Sobi, Inc
$17
Ferring Pharmaceuticals Inc.
$15
Kiniksa Pharmaceuticals International, plc
$13
Horizon Pharma plc
$13
Merck Sharp & Dohme Corporation
$12
Mission Pharmacal Company
$12
Top 3 companies account for 78.8% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AIMOVIG · AMJEVITA · AVSOLA · Actemra · Aquoral · Arcalyst · BENLYSTA · COSENTYX · CYLTEZO · Cimzia · DUPIXENT · EUFLEXXA · EVENITY · Enbrel · HUMIRA · Humira · IDACIO · KEVZARA · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · MONOVISC · Mitigare · OFEV · ORENCIA · ORTHOVISC · Otezla · Otrexup · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · Quzyttir · RAYOS · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · SYNVISC-ONE · TALTZ · TAVNEOS · TREMFYA · Tavneos · Tymlos · XELJANZ · ZTLido
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Rheumatologists in nearby ZIP areas
95
County median income
$74,149
Nearest hospital to ZIP centroid (approximate)
BAYLOR UNIVERSITY MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Nair is a mixed practice specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Nair experienced with infliximab infusion (remicade)?
Based on Medicare claims data, Dr. Nair performed 4,340 infliximab infusion (remicade) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Nair receive payments from pharmaceutical companies?
Yes. Dr. Nair received a total of $52,943 from 41 companies across 1,005 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Nair's costs compare to other rheumatologists in Dallas?
Dr. Nair's average Medicare payment per service is $26. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Nair) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Dallas
Browse rheumatologists in Dallas ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in TX
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in TX
Which TX rheumatologists receive the most from drug and device companies.
By company
AbbVie, Inc. Payments to Doctors
See all physicians who received payments from AbbVie, Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology